US Open – ECB delivers, Lagarde presser sinks rally, US eyes China Media, Continuing Claims rise, Oil off lows on Europe’s response, Gold pares gain
AstraZeneca Partners With Accent To Develop Novel Cancer Treatments
WHO restarts trial of COVID-19 drug hydroxychloroquine
5 Promising Covid-19 Vaccines Picked For Trump’s Operation Warp Speed
Gun stocks soar as background checks soar past 3M
Scientists tap the world's most powerful computers in the race to understand and stop the coronavirus
Macro Briefing | 3 June 2020
Study panning anti-malaria drug Trump took against COVID faces new questions
Fannie Mae’s release from conservatorship progresses
HCQ Misinformation Can Be Deadly: Let Patients Decide
Why Ford, Chanel and other companies pitch in during a crisis – without the government ordering them to
Aussie dollar continues to surge as hopes pinned on recovery
June Monthly
Australian dollar on the rise as focus shifts back to pandemic
US Dollar Losses are Extended, but Momentum Stalls in the European Morning
Macro Briefing | 1 June 2020
Market Breaks Above 200-DMA. Is The Bull Back? 05-30-20
Exclusive: Sanofi stops enrolling COVID-19 patients in hydroxychloroquine trials
US Close – Risk rally resumes as Trump walks fine line, Oil extends higher after phase-one deal left alone, Gold softer post Trump
10 things we learned at Brookings in May
Tech Stocks Offer A Rare Bright Spot For 2020 Sector Returns
Month-End Profit-Taking Weighs on Equities as the Euro Pops Above $1.11
Hydroxychloroquine combination risky for cancer patients with COVID-19: study
Asia Booking Profits Ahead of the Weekend
The Hill: “White House to forgo summer economic forecast amid COVID-19, breaking precedent”
The impact of the second wave of coronavirus on the market
GSK to produce a billion doses of COVID-19 vaccine booster by 2021
Escalating Tensions, Calm Markets
Coronavirus – Weekly update – 27 May 2020
France, Italy, Belgium act to stop use of hydroxychloroquine for COVID-19 on safety fears